137 related articles for article (PubMed ID: 35793638)
1. Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients.
Di Donato V; D'Oria O; Giannini A; Bogani G; Fischetti M; Santangelo G; Tomao F; Palaia I; Perniola G; Muzii L; Benedetti Panici P
Gynecol Obstet Invest; 2022; 87(3-4):191-199. PubMed ID: 35793638
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Impact of Comorbidities on Endometrial Lesions Using the Charlson Comorbidity Index in Western Romania.
Furau A; Tit DM; Furau C; Bungau S; Furau G; Toma MM; Cirstoveanu CG; Petre I; Todor DS; Romosan RS; Craina M
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577868
[No Abstract] [Full Text] [Related]
3. Predictive Capacity of 3 Comorbidity Indices in Estimating Survival Endpoints in Women With Early-Stage Endometrial Carcinoma.
Al Feghali KA; Robbins JR; Mahan M; Burmeister C; Khan NT; Rasool N; Munkarah A; Elshaikh MA
Int J Gynecol Cancer; 2016 Oct; 26(8):1455-60. PubMed ID: 27488218
[TBL] [Abstract][Full Text] [Related]
4. Potential competing risk of death in older high-risk endometrial carcinoma patients: Results from a multicentric retrospective cohort.
Gorgeu V; Borghese B; Koual M; Just PA; Lefrere Belda MA; Delanoy N; Durdux C; Chapron C; Goldwasser F; Gervais C; Blons H; Terris B; Badoual C; Taly V; Laurent-Puig P; Bats AS; Alexandre J; Beinse G
Gynecol Oncol; 2022 Aug; 166(2):269-276. PubMed ID: 35643579
[TBL] [Abstract][Full Text] [Related]
5. Type I Versus Type II Endometrial Cancer: Differential Impact of Comorbidity.
Noer MC; Antonsen SL; Ottesen B; Christensen IJ; Høgdall C
Int J Gynecol Cancer; 2018 Mar; 28(3):586-593. PubMed ID: 29303936
[TBL] [Abstract][Full Text] [Related]
6. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
7. Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer.
Robbins JR; Gayar OH; Zaki M; Mahan M; Buekers T; Elshaikh MA
Gynecol Oncol; 2013 Dec; 131(3):593-7. PubMed ID: 24125752
[TBL] [Abstract][Full Text] [Related]
8. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
9. Does Age-Adjusted Charlson Comorbidity Score Impact Survival Endpoints in Women with Federation of Gynecology and Obstetrics-Stage III Endometrial Cancer?
Ghanem AI; Modh A; Burmeister C; Munkarah AR; Elshaikh MA
Gynecol Obstet Invest; 2018; 83(3):290-298. PubMed ID: 29518778
[TBL] [Abstract][Full Text] [Related]
10. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
[TBL] [Abstract][Full Text] [Related]
11. Surgical and oncologic outcomes in surgically treated women 80 years and older with endometrioid endometrial cancer as a function of their comorbidities.
AlAshqar A; Ghazarian M; Webster EM; Upadhyay A; Azodi M; Schwartz PE; Ratner E; Altwerger G
Gynecol Oncol Rep; 2023 Oct; 49():101240. PubMed ID: 37636496
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
[TBL] [Abstract][Full Text] [Related]
13. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
Yang CC; Fong Y; Lin LC; Que J; Ting WC; Chang CL; Wu HM; Ho CH; Wang JJ; Huang CI
Eur J Cardiothorac Surg; 2018 Jan; 53(1):235-240. PubMed ID: 29106506
[TBL] [Abstract][Full Text] [Related]
14. The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer.
Truong PT; Kader HA; Lacy B; Lesperance M; MacNeil MV; Berthelet E; McMurtrie E; Alexander S
Am J Clin Oncol; 2005 Apr; 28(2):157-64. PubMed ID: 15803010
[TBL] [Abstract][Full Text] [Related]
15. Magnitude of the Age-Advancement Effect of Comorbidities in Colorectal Cancer Prognosis.
Boakye D; Walter V; Jansen L; Martens UM; Chang-Claude J; Hoffmeister M; Brenner H
J Natl Compr Canc Netw; 2020 Jan; 18(1):59-68. PubMed ID: 31910379
[TBL] [Abstract][Full Text] [Related]
16. Charlson Comorbidity Index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization.
Di Iorio B; Cillo N; Cirillo M; De Santo NG
Int J Artif Organs; 2004 Apr; 27(4):330-6. PubMed ID: 15163067
[TBL] [Abstract][Full Text] [Related]
17. The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder.
Mayr R; May M; Burger M; Martini T; Pycha A; Dechet C; Lodde M; Comploj E; Wieland WF; Denzinger S; Otto W; Aziz A; Fritsche HM; Gierth M
Urol Int; 2014; 93(3):303-10. PubMed ID: 25139069
[TBL] [Abstract][Full Text] [Related]
18. Age-adjusted Charlson comorbidity index scores as predictor of survival in colorectal cancer patients who underwent surgical resection and chemoradiation.
Wu CC; Hsu TW; Chang CM; Yu CH; Lee CC
Medicine (Baltimore); 2015 Jan; 94(2):e431. PubMed ID: 25590852
[TBL] [Abstract][Full Text] [Related]
19. Modified Charlson comorbidity index for predicting survival after liver transplantation.
Volk ML; Hernandez JC; Lok AS; Marrero JA
Liver Transpl; 2007 Nov; 13(11):1515-20. PubMed ID: 17969207
[TBL] [Abstract][Full Text] [Related]
20. Influence of Comorbidity on the Risk of Death: A Single Institution Study of 1132 Women With Early-stage Uterine Cancer.
Elshaikh MA; Vance S; Kamal M; Burmeister C; Hanna RK; Rasool N; Siddiqui F
Am J Clin Oncol; 2017 Apr; 40(2):183-188. PubMed ID: 25222075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
